Tmax in three treatment, three period, three sequence design [Nonparametrics]

posted by libaiyi – China, 2019-04-09 09:15 (1837 d 14:20 ago) – Posting: # 20134
Views: 3,052

Dear all,

I have a question about Wilcoxon signed rank test on Tmax. In a three treatment, three period, three sequece design (two test formulations and one reference formulation with the sequences as T1-R-T2, R-T2-T1, and T2-T1-R), can we use Wilcoxon signed rank test for Tmax? If not, what can we do to statistically evaluate Tmax?

Thanks in advance!

Best,

Libaiyi

Complete thread:

UA Flag
Activity
 Admin contact
22,988 posts in 4,825 threads, 1,657 registered users;
102 visitors (0 registered, 102 guests [including 6 identified bots]).
Forum time: 23:35 CEST (Europe/Vienna)

The only way to comprehend what mathematicians mean by Infinity
is to contemplate the extent of human stupidity.    Voltaire

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5